Disease Prevention and Control Guidelines

• Biosafety
• Chronic Diseases
  • Arthritis
  • Cancer
  • Chronic Fatigue Syndrome
  • Chronic Respiratory Diseases
  • Diabetes
  • Hypertension
  • Mental Illness
• Group A Streptococcal Disease
• Hepatitis C
• HIV/AIDS
• Infection Control
• Laboratory
• Sexually Transmitted Infections (STI)
• Tuberculosis (TB)
• Vaccines and Vaccine-Preventable Diseases

Biosafety

• Pathogen Safety Data Sheets and Risk Assessment
• Guidelines for Biomedical Facilities using Sheep as Research Animals (2000)

Chronic Diseases

Arthritis

• American College of Rheumatology - Practice guidelines for rheumatic disease
• Getting a Grip Project - Arthritis Best Practices Guidelines (PDF document)
• AHRQ National Guideline Clearinghouse
• Rheumatoid Arthritis: Diagnosis and Management, CMA(PDF document)
• Diagnostic Guidelines, The John Hopkins Arthritis Center

Cancer

• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Breast Cancer

• Canadian Task Force on Preventive Health Care guidance on breast cancer screening
• Canadian Medical Association, Clinical Practice Guidelines For the Care and Treatment of Breast Cancer, 2005
• Society of Obstetricians and Gynaecologists of Canada, Use of Hormonal Replacement Therapy After Treatment of Breast Cancer, 2004(PDF document)
• Alberta Ministry of Health and Wellness: Breast Cancer
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Cervical Cancer

• Should I be screened for Cervical cancer
• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• Cancer Care Ontario, Chemotherapy for Recurrent, Metastatic, or Persistent Cervical Cancer: A Clinical Practice Guideline, 2006 (PDF document)
• Cancer Care Ontario, Primary Treatment for Locally Advanced Cervical Cancer: Concurrent Platinum-based Chemotherapy and Radiation Practice Guideline Report #4-5 (PDF document)
• American Journal of Obstetrics & Gynecology, 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests (published in 2007) (PDF document)
• Alberta Ministry of Health and Wellness: Cervical Cancer
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Colorectal Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• B.C. Ministry of Health: Follow-up of Patients after Curative Resection of Colorectal Cancer, 2004 (PDF document)
• B.C. Ministry of Health: Detection of Colorectal Neoplasms in Asymptomatic Patients, (full guideline) (PDF document)
• B.C. Ministry of Health: Detection of Colorectal Cancer: A Guide for Patients (PDF document)
• Alberta Ministry of Health and Wellness: Colorectal Cancer
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Lung Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• British Columbia Cancer Agency, Lung Cancer Management Guidelines
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Melanoma Skin Cancer

• Cancer Care Ontario, Temozolomide for the Treatment of Metastatic Melanoma: A Clinical Practice Guideline (PDF document)
• Cancer Care Ontario, Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline (PDF document)
• Cancer Care Ontario, Systemic Adjuvant Therapy for Patients at High Risk for Recurrent Melanoma: A Clinical Practice Guideline (PDF document)
• Cancer Care Ontario, Single-Agent Interleukin-2 in the Treatment of Metastatic Melanoma: A Clinical Practice Guideline (PDF document)
• Cancer Care Ontario, Screening for Skin Cancer: A Clinical Practice Guideline (PDF document)
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Non Melanoma Skin Cancer

• Non-melanoma skin cancer: Guidelines for treatment and management in Australia
• Management of nonmelanoma skin cancer in 2007
• Guidelines Support Photodynamic Therapy for Several Nonmelanoma Skin Cancers
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Prostate Cancer

• Cancer Care Ontario, Program in Evidence-Based Care: Practice Guidelines
• American Urological Association, Guideline For the Management of Clinically Localized Prostate Cancer: 2007 Update (PDF document)
• Ontario Ministry of Health, Ontario Prostate Specific Antigen (PSA) Clinical Guidelines, summary 2002 update
• Canadian Medical Association, CMA Infobase: Clinical Practice Guidelines
• B.C. Cancer Agency, various guidelines

Chronic Fatigue Syndrome

• Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Clinical Case Definition and Guidelines for Medical Practitioners (PDF document)
• Chronic Fatigue Syndrome Myalgic Encephalomyelitis – A Primer for Clinical Practioners (PDF document)

Chronic Respiratory Diseases

• Diagnosis and treatment of sleep disordered breathing in adults (PDF document)

Asthma

• Canadian Asthma Consensus Guidelines

Chronic Obstructive Pulmonary Disease (COPD)

• Chronic Obstructive Pulmonary Disease (COPD)

Diabetes

• Canadian Diabetes Association - Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada
• Colleges of Physicians and Surgeons from individual provinces or territories may have developed their own clinical practice guidelines for particular circumstances.
• Canadian Task Force on Preventive Health Care guidance on screening for Type 2 diabetes

Hypertension

• Canadian Task Force on Preventive Health Care guidance on hypertension screening and management
• 2009 CHEP Recommendations for the Management of Hypertension

Mental Illness

• The Canadian Psychiatric Association Clinical Practice Guidelines

Group A Streptococcal Disease

• Guidelines for the Prevention and Control of Invasive Group A Streptococcal Disease (October 2006)

Hepatitis C

• Management and Treatment of Hepatitis C Virus in Patients with HIV and Hepatitis C Virus Coinfection: A Practical Guide for Health Care Professionals. The Canadian Journal of Infectious Diseases & Medical Microbiology. Sept/Oct 2007;18(5):293-303.
• Infection Control Guidelines - Prevention and Control of Occupational Infections in Health Care CCDR Volume 28S1, March 2002
• Nutrition Tips for People with Hepatitis C:
  Helping You Feel Your Best!
  Dealing With Discomforts
  (September 2003)
• Management Guidelines for the HCV-HIV Co-infected Adult (October 2000)
  -Executive Summary

• Reproductive Care of Women Living with Hep C Infection (October 2000)

HIV/AIDS

• Guides for People Living with HIV/AIDS

• Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS) (1996)*

• Guidelines for the Identification, Investigation and Treatment of Individuals with Concomitant Tuberculosis and HIV Infection (1992)

Infection Control

• Environmental Sanitation Practices to Control the Spread of Communicable Disease in Passenger Conveyances and Terminals - June 23, 2014
• Routine Practices and Additional Precautions for Preventing the Transmission of Infection in Healthcare Settings (2013)
  To obtain a copy of this report, send your request to ccdic-clmti@phac-aspc.gc.ca
• Seasonal Influenza - Infection Prevention and Control Guidance for Management in Home Care Settings - New - December 2012
• Nosocomial and Occupational Infections
• Infection Prevention and Control Guideline for Flexible Gastrointestinal Endoscopy and Flexible Bronchoscopy (2011)
  • NOTICE: Recommended practices for the prevention of endoscopy-related infections (2016)
• Seasonal Influenza - Guidance: Infection Prevention and Control Measures for Healthcare Workers in Acute Care and Long-term Care Settings (2010)
• Infection Prevention and Control Guidelines for the Prevention of Healthcare-Associated Pneumonia (2010)
  To obtain a copy of this document, send your request to ccdic-clmti@phac-aspc.gc.ca
• Essential Resources for Effective Infection Prevention and Control Programs: A Matter of Patient Safety--A Discussion Paper (2010)
• Classic Creutzfeldt-Jakob Disease in Canada
  Quick Reference Guide 2007
• Anaphylaxis: Statement on Initial Management in Non-hospital Settings (1995)
• Classic Creutzfeldt-Jakob Disease in Canada (2002)*
• Advisory Notice: Infection Control for Creutzfeldt-Jakob Disease (1996)*
• Foot Care by Health Care Providers (1997)*
• Infection Control Guidelines - Hand Washing, Cleaning, Disinfection and Sterilization in Health Care (PDF document)
• Preventing Infections Associated with Indwelling Intravascular Access Devices (1997) (*)
• Guidelines for Control of Meningococcal Disease (1994)
• Construction-related Nosocomial Infections in Patients in Health Care Facilities: Decreasing the Risk of Aspergillus, Legionella and Other Infections
• Prevention and Control of Occupational Infections in Health Care (2002) (PDF document)
• Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and Other Institutional Settings (1996)*
• Canadian Contingency Plan for Viral Hemorrhagic Fevers and Other Related Diseases (1997)*

Laboratory

• Laboratory Biosafety Guidelines - 3rd Edition (2004)
• Material Safety Data Sheets (MSDS) (1997)
• Measles Surveillance: Guidelines for Laboratory Support (1999)*
• Guidelines for Biomedical Facilities using Sheep as Research Animals (2000)

Sexually Transmitted Infections (STI)

• Canadian Guidelines for Sexual Health Education
• Canadian Guidelines on Sexually Transmitted Infections
• Lymphogranuloma venereum (LGV) in Canada: Recommendations for Diagnosis and Treatment and Protocol for National Enhanced Surveillance (May 2005)
• Interim Recommendations: Alternatives to Spectinomycin for Gonorrhea Treatment (September 2001) (92 KB) in PDF Format Only

Tuberculosis (TB)

• Guidelines regarding departure from Canada of persons with suspected respiratory tuberculosis (TB), untreated active respiratory TB or partially treated active respiratory TB - (Version 2006.07.18)
• Statement on Bacille Calmette Guérin (BCG) Vaccine (2004)
• Guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arriving in Canada: a summary (2003)
• Recommendations for the Screening and Prevention of Tuberculosis in Patients with HIV and the Screening for HIV in Tuberculosis Patients and Their Contacts (2002)
• Canadian guidelines for the investigation and follow-up of individuals under medical surveillance for tuberculosis after arrival in Canada (2001)
• Mycobacterium tuberculosis - Material Safety Data Sheet - Infectious Substances (2001)
• Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis (1998)
• Guidelines for Preventing the Transmission of Tuberculosis in Canadian Health Care Facilities and other Institutional Settings (1996)

Vaccines and Vaccine-Preventable Diseases

Adverse Events (associated with vaccines)

• Guidelines for Reporting Adverse Events Associated with Vaccine Products (2000)

Bacille Calmette Guérin (BCG)

• Statement on Bacille Calmette Guérin (BCG) Vaccine - 1 December 2004
• Erratum

Cholera

• Statement on New Oral Cholera and Travellers' Diarrhea Vaccination (2005)

Cochlear Implant Recipients

• Immunization Recommendations for Cochlear Implant Recipients (2003)

Diptheria

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis - 15 October 2005
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (May 2000)
• Guidelines for the Control of Diphtheria in Canada (July 1998)

Encephalitis

• Statement on Protection Against Japanese Encephalitis (2011)

Haemophilus Influenzae Type B

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Supplementary Statement on Newly Licensed Haemophilus Influenzae Type B (Hib) Conjugate Vaccines in Combination with other Vaccines Recommended for Infants (1994)

Hepatitis

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Hepatitis B Vaccine, Update to the 2002 Canadian Immunization Guide 15 May 2004
• Update on Hepatitis A Vaccine (AVAXIM^®, Aventis Pasteur), 2001
• Statement on Alternate Adolescent Schedule for Hepatitis B Vaccine, 2000
• Supplementary Statement on Hepatitis A Vaccine, 2000
• Statement on Combination Vaccines Against Hepatitis A And Hepatitis B (1999)
• Supplementary Statement on Hepatitis Prevention - Hepatitis A and Hepatitis B Combination Vaccine for Children (1999)
• Supplementary Statement on Hepatitis Prevention (1997)
• Supplementary Statement on Hepatitis A Prevention (1996)
• Report of the Hepatitis B Working Group (1994)

Human Papillomavirus

• Update On Human Papillomavirus (HPV) Vaccines - (January 2012)
• Canadian Immunization Committee Report: Recommendations on a Human Papillomavirus Immunization Program  (December 2007)
• Statement on Human Papillomavirus Vaccine - 15 February 2007

Immunization

• Evidence-based recommendations for immunization – Methods of the National Advisory Committee on Immunization - January 2009
• Table on Vaccines Currently Approved for Use in Canada, updated as of March 2008 (PDF document - 119 KB - 9 pages) - Opens in a new window
• Canadian Immunization Guide, Seventh Edition, 2006
• Guidelines For Childhood Immunization Practices
• Canadian National Report on Immunization, 2006
• Canadian National Report on Immunization, 1996

Influenza

• Recommendations on the use of live, attenuated influenza vaccine (FluMist^®): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012 NEW
• Recommendations on the use of MF59-Adjuvanted Trivalent Influenza Vaccine (Fluad^®): Supplemental Statement of Seasonal Influenza Vaccine for 2011-2012
• Statement on Seasonal Influenza Vaccine for 2011–2012
• Addendum to the 2010-2011 Seasonal Trivalent Inactivated Influenza Vaccine
• Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2010-2011
• Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2009-2010
• Statement on Influenza Vaccination for the 2008-2009 Season
• Statement on Influenza Vaccination for the 2007-2008 Season - 1 July 2007
• Travel, Influenza, and Prevention (2005)
• Statement On Influenza Vaccination for The 2006-2007 Season
• Update on Influenza Vaccination For the 2005-2006 Season - 1 March 2006
• Statement on Influenza Vaccination for the 2005-2006 Season (2005)
• Statement on Influenza Vaccination for the 2003-2004 Season (2003)
• Statement on Influenza Vaccination for the 2002-2003 Season (2002)
• Supplementary Statement for the 2002-2003 Influenza Season: Update on Oculo-respiratory syndrome in Association with Influenza Vaccination (2002)
• Supplementary Statement for The 2001-2002 Season: Influenza Vaccination of Persons Who Experienced Oculo-Respiratory Syndrome Following Previous Influenza Vaccination (ACS-7) - 15 November 2001
• Statement on Influenza Vaccination for the 2001-2002 Season (2001)
• Supplementary statement on influenza vaccination: continued use of Fluviral^® influenza vaccine in the 2000-2001 season (ACS-1) - 15 January 2001
• Statement on Influenza Vaccination for the 2000-2001 Season - 1 June 2000

MMR (Measles, Mumps, Rubella)

• Supplementary Statement on MMR Vaccine and Anaphylactic Hypersensitivity to Egg or Egg-Related Antigens (1996)

MMRV (Measles, Mumps, Rubella, Varicella)

• Statement on Measles-Mumps-Rubella-Varicella Vaccine - September 2010

Measles

• Guidelines for the Prevention and Control of Measles Outbreaks in Canada (2013)
• Statement on Measles-Mumps-Rubella-Varicella Vaccine - September 2010
• Measles Surveillance: Guidelines for Laboratory Support (1998)
• Interim Advisory on Measles Revaccination of Persons with Acquired Immunodeficiency Syndrome (AIDS) (1996)
• Supplementary Statement on Measles Elimination in Canada (1996)
• Guidelines for Control of Measles Outbreaks in Canada (1995)

Meningococcal

• Canadian Immunization Committee Report: Advice for Consideration of Quadrivalent (A, C, Y, W135) Meningococcal Conjugate Vaccine, for use by Provinces and Territories (January 2010)
• Guidelines for the Prevention and Control of Meningococcal Disease - Supplement (2005)
• Update on Meningococcal C Conjugate Vaccines (2005)
• Supplementary Statement on Conjugate Meningococcal Vaccines (2003)
• Statement on Recommended Use of Meningococcal Vaccines (2001)

Mumps

• Statement on Measles-Mumps-Rubella-Varicella Vaccine - September 2010
• Guidelines for the Prevention and Control of Mumps Outbreaks in Canada – Jan. 2010
• Statement on Mumps Vaccine - 1 August 2007

Pertussis

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Proceedings of the National Microbiology Laboratory Pertussis Workshop, March 7, 2006
• Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis - 15 October 2005
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Clarification - Prevention of Pertussis in Adolescents and Adults (2004)
• National Consensus Conference on Pertussis (2003)
• Prevention of Pertussis in Adolescents and Adults (2003)
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (2000)
• Statement on Pertussis Vaccine (1997)
• Statement on Management of Persons Exposed to Pertussis and Pertussis Outbreak Control (1994)

Pneumococcal

• Update on the Use of Conjugate Pneumococcal Vaccines in Childhood – November 2010
• Update on Pediatric Invasive Pneumococcal Disease and Recommended Use of Conjugate Pneumococcal Vaccines – April 2010
• Statement on the recommended use of pneumococcal 23-valent polysaccharide vaccine in homeless persons and injection drug users – September 2008
• Update On the Recommendations For The Routine Use of Pneumococcal Conjugate Vaccine For Infants - 1 May 2006
• Recommendations for use of Pneumococcal 23-Valent Polysaccharide Vaccine During Shortage (2004)
• Statement on the Recommended use of Pneumococcal Conjugate Vaccine: Addendum (2003)
• Immunization Recommendations for Cochlear Implant Recipients (2003)
• Statement on Recommended use of Pneumococcal Conjugate Vaccine (2002)

Poliomyelitis

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)

Rabies

• Recommendations Regarding the Management of Bat Exposures to Prevent Human Rabies - November 2009
• Update on Rabies Vaccines (2005)

Respiratory Syncytial Virus (RSV)

• Statement on the Recommended Use of Monoclonal Anti-RSV Antibody (Palivizumab) - 15 September 2003

Rotavirus

• Updated Statement on the Use of Rotavirus Vaccines (July 2010)
• Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine - January 2008

Rubella

• Statement on Measles-Mumps-Rubella-Varicella Vaccine - September 2010

Smallpox

• Statement on Smallpox Vaccination (2002)

Tetanus

• Statement on the recommended use of pentavalent and hexavalent vaccines (1 February 2007)
• Interval Between Administration of Vaccines Against Diphtheria, Tetanus, and Pertussis - 15 October 2005
• Interchangeability of Diphtheria, Tetanus, Acellular Pertussis, Polio, haemophilus Influenzae Type B Combination Vaccines Presently Approved for Use in Canada for Children < 7 Years of Age (2005)
• Statement On Adult/Adolescent Formulation of Combined Acellular Pertussis, Tetanus, and Diphtheria Vaccine (May 2000)

Thimerosal

• Thimerosal: Updated Statement - 1 July 2007
• Updated Recommendations on the use of Thimerosal-Containing Vaccines in Canada (2005-12-01)
• Statement on Thimerosal (2003)
• Thimerosal in Vaccines (1999)

Typhoid

• Update To The 2002 Canadian Immunization Guide - Typhoid Vaccine - 1 May 2003

Vaccine

• Guidelines for Reporting Adverse Events Associated with Vaccine Products (2000)
• National Vaccine Storage and Handling Guidelines for Immunization Providers - 2015

Varicella

• Statement on Measles-Mumps-Rubella-Varicella Vaccine - September 2010
• Varicella Vaccination Two-Dose Recommendations. - September 2010
• Updated Recommendations For The Use Of Varicella And MMR Vaccines In HIV-infected Individuals - September 2010
• Varizig™ as the varicella zoster immune globulin for the prevention of varicella In at-risk patients (October 15, 2006)
• Update on Varicella (2004)
• NACI Update to Statement on Varicella Vaccine (2002)
• Statement on Recommended Use of Varicella Virus Vaccine (1999)

Zoster

• Statement on the Recommended Use of Herpes Zoster Vaccine – Jan. 2010